Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Internet and Social Media Use in Dermatology Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03913598
Recruitment Status : Completed
First Posted : April 12, 2019
Last Update Posted : September 18, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

Brief Summary:
This study is to assess Internet and social media use in dermatology patients

Condition or disease Intervention/treatment
Dermatologic Diseases Other: patient questionnaire

Detailed Description:
The Internet and social media bear potential in terms of heath care consumer education, prevention of diseases and dissemination of evidence-based information. The use of the internet and social media platforms both by dermatologists and patients is rapidly evolving. In order to improve the presence and visibility of dermatology-related evidence-based informations on the Internet and in social media, the use and behavior of dermatology patients in this context is studied in more detail.

Layout table for study information
Study Type : Observational
Actual Enrollment : 650 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Internet and Social Media Use in Dermatology Patients - a Survey
Actual Study Start Date : March 21, 2019
Actual Primary Completion Date : April 20, 2019
Actual Study Completion Date : April 20, 2019

Intervention Details:
  • Other: patient questionnaire
    self-administered patient questionnaire regarding the different aspects of internet and social media use in dermatology patients


Primary Outcome Measures :
  1. Use of the Internet as a source of medical information [ Time Frame: single time point assessment at baseline ]
    self-administered patient questionnaire regarding motivation to seek for medical information on the Internet

  2. Use of Social media as a source of medical information [ Time Frame: single time point assessment at baseline ]
    self-administered patient questionnaire regarding motivation to seek for medical information in Social media

  3. Duration of Internet/ Social media use by dermatology patients [ Time Frame: single time point assessment at baseline ]
    self-administered patient questionnaire covering duration of Internet/ Social media use (up to 2 hours/ day; 2 to 4 hours/day; more than 4 hours/day)

  4. Quality assessment (by patients) of medical information provided [ Time Frame: single time point assessment at baseline ]
    self-administered patient questionnaire covering quality of medical information provided on the Internet (5 point self-rating scale from very bad to very good)

  5. Impact of internet/social media on the patient-physician relationship [ Time Frame: single time point assessment at baseline ]
    self-administered patient questionnaire covering impact of internet/social media on the patient-physician relationship (self-rating scale: positive/ negative/ no impact)

  6. Previous use of online medical services and online shopping of drugs/medications [ Time Frame: single time point assessment at baseline ]
    self-administered patient questionnaire assessing previous use of online medical services and online shopping of drugs/medications (yes/ no)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Outpatients treated at the Department of Dermatology of University Hospital Basel
Criteria

Inclusion Criteria:

  • Patients treated at the Department of Dermatology of University Hospital Basel

Exclusion Criteria:

  • Insufficient knowledge of German language

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03913598


Locations
Layout table for location information
Switzerland
Department of Dermatology, University Hospital Basel
Basel, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Layout table for investigator information
Principal Investigator: Simon Müller, Dr. med Department of Dermatology, University Hospital Basel

Layout table for additonal information
Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT03913598    
Other Study ID Numbers: 2019-00009; sp19Mueller3
First Posted: April 12, 2019    Key Record Dates
Last Update Posted: September 18, 2019
Last Verified: September 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Basel, Switzerland:
social media use
online medical services
internet use
Additional relevant MeSH terms:
Layout table for MeSH terms
Skin Diseases